Aveanna Q3 revenue $443M (+7.7% YoY), adj EBITDA $24.7M vs $45.8M YoY

Aveanna Healthcare Holdings, Inc.

2022-Q3 EPS reported -$2.29 revenue$1,336,498,000

Revenue $443.0M, up 7.7% YoY; gross margin 30.4% vs 34.0% YoY.
Adjusted net loss per diluted share $(0.03) vs adjusted net income $0.11 in prior year.
Adjusted EBITDA $24.7M (5.6% of revenue) versus $45.8M (11.1% of revenue) in Q3 2021.
CEO cites difficult labor environment and HHH system conversion impact; expects return to normal into 2023.
Liquidity: $63.7M cash, $182.4M revolver available, $140M DDTL for acquisitions.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended October 1, 2022 results: revenue $1,336.5 million.

Period: three and nine-month periods ended October 1, 2022
Revenue: $1,336.5 million
Result: reported results

Exact text from the filing

Revenue was $443.0 million for the three-month period ended October 1, 2022, as compared to $411.3 million for the three-month period ended October 2, 2021, an increase of $31.7 million, or 7.7%.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended October 1, 2022 results: revenue $1,336.5 million.

Period: three and nine-month periods ended October 1, 2022
Revenue: $1,336.5 million
Result: reported results

Exact text from the filing

Revenue was $1,336.5 million for the nine-month period ended October 1, 2022, as compared to $1,264.5 million for the nine-month period ended October 2, 2021, an increase of $72.0 million, or 5.7%.

View on SEC.gov

Browse all earnings releases →

Aveanna Healthcare Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-023858

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.